XML 37 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Revenue, net $ 16,285 $ 17,391 $ 46,139 $ 47,781
Cost of revenue (1) 8,497 [1] 8,935 [1] 22,883 [1] 25,334 [1]
Gross profit 7,788 8,456 23,256 22,447
Operating expenses:        
Research and development (2) 4,702 [2] 5,982 [2] 14,510 [2] 17,531 [2]
Selling, general and administrative (3) 3,557 [3] 3,641 [3] 11,368 [3] 11,132 [3]
Total operating expenses 8,259 9,623 25,878 28,663
Loss from operations (471) (1,167) (2,622) (6,216)
Interest expense and other, net (105) (89) (304) (395)
Gain on sale of patents 0 0 0 1,600
Gain on sale of marketable securities 0 0 0 264
Total other income (expense), net (105) (89) (304) 1,469
Loss before income taxes (576) (1,256) (2,926) (4,747)
Benefit for income taxes (176) (173) (789) (138)
Net loss $ (400) $ (1,083) $ (2,137) $ (4,609)
Net loss per share - basic and diluted $ (0.02) $ (0.06) $ (0.12) $ (0.29)
Weighted average shares outstanding - basic and diluted 18,338 17,905 18,202 15,787
[1] Includes: Additional amortization of non-cancelable prepaid royalty 142 103 430 321 Stock-based compensation 42 34 118 93
[2] Includes: Stock-based compensation 214 214 619 624
[3] Includes: Stock-based compensation 296 260 793 771